Medicina | Free Full-Text | Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
Sorafenib Pharmacodynamics
Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
Sorafenib - Mechanism of Action in treating Advanced Hepatocellular Carcinoma
Mechanism of Action | NEXAVAR® (sorafenib) Global HCP Website
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica
Sorafenib (Nexavar) - Oncology Nurse Advisor
Sorafenib - Wikipedia
Sorafenib: 10 years after the first pivotal trial | Future Oncology
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
View of SUSTAINED RELEASE TABLETS OF SORAFENIB-SILIBININ COMBINATIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA | International Journal of Applied Pharmaceutics
Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma. - Abstract - Europe PMC
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors | Experimental & Molecular Medicine
Mechanism of action of bevacizumab, sorafenib, and sunitinib. Diagram... | Download Scientific Diagram
TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma - Lai - 2019 - Molecular Oncology - Wiley Online Library
Pexa-Vec/Nexavar Combination Fails Phase III Trial in Liver Cancer
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
Evolving role of Sorafenib in the management of hepatocellular carcinoma
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma. - Abstract - Europe PMC
Mechanism of Action | Multikinase Inhibitors
Frontiers | Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma | Pharmacology
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
Systemic Therapies in Hepatocellular Carcinoma
